Stimulants in bipolar disorder: Beyond common beliefs

CNS Spectrums

Volumn 15, Issue 7, 2010, Pages 469-470

  Hensch, Tilman ^a   Himmerich, Hubertus ^a   Ulrich, Hegerl ^b  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b UNIVERSITY HOSPITAL LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; METHYLPHENIDATE; MODAFINIL; MOOD STABILIZER; PLACEBO; PSYCHOSTIMULANT AGENT; CENTRAL STIMULANT AGENT;

ATTENTION DEFICIT DISORDER; BIPOLAR DEPRESSION; BIPOLAR DISORDER; COMORBIDITY; DIFFERENTIAL DIAGNOSIS; DRUG ACTIVITY; DRUG CONTRAINDICATION; DRUG TOLERABILITY; EMOTIONAL DISORDER; HEALTH BELIEF; HUMAN; LETTER; MANIA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SLEEP; TREATMENT RESPONSE; YOUNG MANIA RATING SCALE;

BIPOLAR DISORDER; CENTRAL NERVOUS SYSTEM STIMULANTS; HUMANS;

EID: 81755185915     PISSN: 10928529     EISSN: None     Source Type: Journal    
DOI: 10.1017/s1092852900000390     Document Type: Letter

References (29)

1. McIntyre R. Bipolar disorder and ADHD: clinical concerns. CNS Spectr. 2009;14(7 Suppl 6):8-9.
2. Hegerl U, Olbrich S, Schoenknecht P, Sander C. [Manic behavior as an autoregulatory attempt to stabilize vigilance]. Nervenarzt. 2008;79(11):1283-1290.
3. Hegerl U, Sander C, Olbrich S, Schoenknecht P. Are psycho-stimulants a treatment option in mania? Pharmacopsychiatry. 2009;42(5):169-174.
4. Hegerl U, Himmerich H, Engmann B, Hensch T. Mania and attention-deficit/hyperactivity disorder: common symptomatology, common pathophysiology and common treatment? Curr Opin Psychiatry. 2010;23(1):1-7.
5. Schoenknecht P, Olbrich S, Sander C, Spindler P, Hegerl U. Treatment of acute mania with modafinil monotherapy. Biol Psychiatry. 2010;67(11):e55-e57.
6. Bschor T, Müller-Oerlinghausen B, Ulrich G. Decreased level of EEG-vigilance in acute mania as a possible predictor for a rapid effect of methylphenidate: a case study. Clin Electroencephal. 2001;32(1):36-39.
7. Hensch T, Himmerich H, Hegerl U. Attention deficit hyperactivity disorder and bipolar disorder: common causes common cure? J Atten Disord. In press.
8. Gelperin K, Phelan K. Psychiatric adverse events associated with drug treatment of ADHD: review of postmarketing safety data. FDA Report PID D050243. US Food and Drug Administration, March 3, 2006. Available at: www.fda.gov/ohrms/dockets/ac/06/briefing/2006-4210b_11_01_AdverseEvents.pdf. Accessed June 2010.
9. Mosholder A. Psychiatric adverse events in clinical trials of drugs for ADHD. FDA Report PID D060163. US Food and Drug Administration, March 3, 2006. Available at: http://www.fda.gov/ohrms/dockets/ac/06/briefing/2006-4210b_10_01_Mosholder.pdf. 3-3-2006. Accessed June 2010.
10. Phelan K. Summary of psychiatric and neurological adverse events from June 2005 1-year post pediatric exclusivity reviews of Concerta and other methylphenidate products. US Food and Drug Administration, 2006. Available at: www.fda.gov/ohrms/dockets/ac/06/briefing/2006-4210b_09_01_Methsummary.pdf. Accessed June 2010.
11. Phelan K. One year post-pediatric exclusivity postmarketing adverse event review: Adderall XR. FDA Report PID D040761. US Food and Drug Administration, Jan 5, 2006. Available at: www.fda.gov/ohrms/dockets/ac/06/briefing/2006-4210b_05_02_AdderallSafetyReview.pdf. Accessed June 2010.
12. Ross RG. Psychotic and manic-like symptoms during stimulant treatment of attention deficit hyperactivity disorder. Am J Psychiatry. 2006;163(7):1149-1152.
13. Reimherr FW, Williams ED, Strong RE, Mestas R, Soni P, Marchant BK. A double-blind, placebo-controlled, crossover study of osmotic release oral system methylphenidate in adults with ADHD with assessment of oppositional and emotional dimensions of the disorder. J Clin Psychiatry. 2007;68(1):93-101.
14. Galanter CA, Carlson GA, Jensen PS, et al. Response to methylphenidate in children with attention deficit hyperactivity disorder and manic symptoms in the multimodal treatment study of children with attention deficit hyperactivity disorder titration trial. J Child Adolesc Psychopharmacol. 2003;13(2):123-136.
15. Waxmonsky J, Pelham WE, Gnagy E, et al. The efficacy and tolerability of methylphenidate and behavior modification in children with attention-deficit/hyperactivity disorder and severe mood dysregulation. J Child Adolesc Psychopharmacol. 2008;18(6):573-588.
16. Kowatch RA, Sethuraman G, Hume JH, Kromelis M, Weinberg WA. Combination pharmacotherapy in children and adolescents with bipolar disorder. Biol Psychiatry. 2003;53(11):978-984.
17. Kummer A, Teixeira A. Methylphenidate in attention deficit hyperactivity disorder and bipolar disorder. Australas Psychiatry. 2008;16(6):458-459.
18. Scheffer RE, Kowatch RA, Carmody T, Rush AJ. Randomized, placebo-controlled trial of mixed amphetamine salts for symptoms of comorbid ADHD in pediatric bipolar disorder after mood stabilization with divalproex sodium. Am J Psychiatry. 2005;162(1):58-64.
19. Findling RL, Short EJ, McNamara NK, et al. Methylphenidate in the treatment of children and adolescents with bipolar disorder and attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2007;46(11):1445-1453.
20. Zeni CP, Tramontina S, Ketzer CR, Pheula GF, Rohde LA. Methylphenidate combined with aripiprazole in children and adolescents with bipolar disorder and attention-deficit/hyperactivity disorder: a randomized crossover trial. J Child Adolesc Psychopharmacol. 2009;19(5):553-561.
21. Carlson PJ, Merlock MC, Suppes T. Adjunctive stimulant use in patients with bipolar disorder: treatment of residual depression and sedation. Bipolar Disord. 2004;6(5):416-420.
22. El-Mallakh RS. An open study of methylphenidate in bipolar depression. Bipolar Disord. 2000;2(1):56-59.
23. Fernandes PP, Petty F. Modafinil for remitted bipolar depression with hypersomnia. Ann Pharmacother. 2003;37(12):1807-1809.
24. Lydon E, El-Mallakh RS. Naturalistic long-term use of methylphenidate in bipolar disorder. J Clin Psychopharmacol. 2006;26(5):516-518.
25. Nasr S, Wendt B, Steiner K. Absence of mood switch with and tolerance to modafinil: a replication study from a large private practice. J Affect Disord. 2006;95(1-3):111-114.
26. Frye MA, Grunze H, Suppes T et al. A placebo-controlled evaluation of adjunctive modafinil in the treatment of bipolar depression. Am J Psychiatry. 2007;164(8):1242-1249.
27. Plante DT. Treatment-emergent hypomania or mania with modafinil. Am J Psychiatry. 2008;165(1):134-135.
28. Plante DT, Winkelman JW. Sleep disturbance in bipolar disorder: therapeutic implications. Am J Psychiatry. 2008;165(7):830-843.
29. Sobanski E, Schredl M, Kettler N, Alm B. Sleep in adults with attention deficit hyperactivity disorder (ADHD) before and during treatment with methylphenidate: a controlled polysomnographic study. Sleep. 2008;31(3):375-381